{"id":"https://openalex.org/W7204836925","doi":"https://doi.org/10.1158/2767-9764.c.8684414","title":"Data from Ex Vivo Tumor-Derived Organoid Pharmacotyping Identifies Personalized Therapeutic Options for Patients with Biliary Tract Cancer","display_name":"Data from Ex Vivo Tumor-Derived Organoid Pharmacotyping Identifies Personalized Therapeutic Options for Patients with Biliary Tract Cancer","publication_year":2026,"publication_date":"2026-08-31","ids":{"openalex":"https://openalex.org/W7204836925","doi":"https://doi.org/10.1158/2767-9764.c.8684414"},"language":"en","primary_location":{"id":"doi:10.1158/2767-9764.c.8684414","doi":"https://doi.org/10.1158/2767-9764.c.8684414","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.c.8684414","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2767-9764.c.8684414","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055547973","display_name":"Anne B. Richardson","orcid":"https://orcid.org/0000-0001-9846-7706","observed_orcids":["https://orcid.org/0000-0001-9846-7706"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Annie Blair Richardson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9846-7706","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148796521","display_name":"Payel Chatterjee","orcid":"https://orcid.org/0009-0004-7474-9740","observed_orcids":["https://orcid.org/0009-0004-7474-9740"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Payel Chatterjee","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-7474-9740","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076719905","display_name":"Rachele Rosati","orcid":"https://orcid.org/0009-0005-6731-3954","observed_orcids":["https://orcid.org/0009-0005-6731-3954"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rachele Rosati","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0005-6731-3954","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054905861","display_name":"Alex C. Rajewski","orcid":"https://orcid.org/0000-0003-3475-1999","observed_orcids":["https://orcid.org/0000-0003-3475-1999"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alex Rajewski","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3475-1999","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113934312","display_name":"Robert L. Diaz","orcid":"https://orcid.org/0009-0005-7880-0758","observed_orcids":["https://orcid.org/0009-0005-7880-0758"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert L. Diaz","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0005-7880-0758","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053334479","display_name":"Lauren R. Appleyard","orcid":"https://orcid.org/0009-0007-0492-3063","observed_orcids":["https://orcid.org/0009-0007-0492-3063"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lauren R. Appleyard","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0007-0492-3063","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078025339","display_name":"Shalini E. Pereira","orcid":"https://orcid.org/0009-0008-8610-6645","observed_orcids":["https://orcid.org/0009-0008-8610-6645"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shalini Pereira","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0008-8610-6645","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080158021","display_name":"Brady M. Bernard","orcid":"https://orcid.org/0000-0003-2118-9829","observed_orcids":["https://orcid.org/0000-0003-2118-9829"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brady Bernard","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2118-9829","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054771911","display_name":"Milind M. Javle","orcid":"https://orcid.org/0000-0001-9158-0941","observed_orcids":["https://orcid.org/0000-0001-9158-0941"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Milind M. Javle","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9158-0941","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073989587","display_name":"Gentry Teng King","orcid":"https://orcid.org/0000-0002-7525-8802","observed_orcids":["https://orcid.org/0000-0002-7525-8802"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gentry G. King","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7525-8802","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039939671","display_name":"Adam Diehl","orcid":"https://orcid.org/0000-0003-4984-8128","observed_orcids":["https://orcid.org/0000-0003-4984-8128"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adam Diehl","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4984-8128","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113286006","display_name":"William Proctor Harris","orcid":"https://orcid.org/0000-0002-3977-4017","observed_orcids":["https://orcid.org/0000-0002-3977-4017"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William Proctor Harris","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3977-4017","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088856020","display_name":"Sameek Roychowdhury","orcid":"https://orcid.org/0000-0002-8297-3038","observed_orcids":["https://orcid.org/0000-0002-8297-3038"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sameek Roychowdhury","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8297-3038","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112265164","display_name":"Christopher J. Kemp","orcid":"https://orcid.org/0000-0001-7238-8452","observed_orcids":["https://orcid.org/0000-0001-7238-8452"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher J. Kemp","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7238-8452","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5072279288","display_name":"Carla Grandori","orcid":"https://orcid.org/0009-0009-4682-9731","observed_orcids":["https://orcid.org/0009-0009-4682-9731","https://orcid.org/0000-0001-9109-410X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carla Grandori","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-4682-9731","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11364","display_name":"Cholangiocarcinoma and Gallbladder Cancer Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11364","display_name":"Cholangiocarcinoma and Gallbladder Cancer Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12460","display_name":"Pediatric Hepatobiliary Diseases and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/biliary-tract-cancer","display_name":"biliary tract cancer","score":1.0},{"id":"https://openalex.org/keywords/patient-derived-tumor-organoids","display_name":"patient-derived tumor organoids","score":0.8820000290870667},{"id":"https://openalex.org/keywords/ex-vivo-drug-sensitivity-testing","display_name":"ex vivo drug sensitivity testing","score":0.875},{"id":"https://openalex.org/keywords/pharmacotyping","display_name":"pharmacotyping","score":0.875},{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":0.7710000276565552},{"id":"https://openalex.org/keywords/dasatinib-resistance","display_name":"dasatinib resistance","score":0.6370000243186951},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.777999997138977},{"id":"https://openalex.org/keywords/pi3k-inhibitors","display_name":"PI3K inhibitors","score":0.7580000162124634},{"id":"https://openalex.org/keywords/bcl2-inhibitors","display_name":"BCL-2 inhibitor","score":0.718999981880188},{"id":"https://openalex.org/keywords/bet-inhibitors","display_name":"BET inhibitors","score":0.628000020980835},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.5429999828338623},{"id":"https://openalex.org/keywords/personalized-medicine","display_name":"personalized medicine","score":0.5059999823570251},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.4650000035762787}],"concepts":[{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.8562999963760376},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7871000170707703},{"id":"https://openalex.org/C31695470","wikidata":"https://www.wikidata.org/wiki/Q11293125","display_name":"Organoid","level":2,"score":0.7752000093460083},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5649999976158142},{"id":"https://openalex.org/C32220436","wikidata":"https://www.wikidata.org/wiki/Q2072214","display_name":"Personalized medicine","level":2,"score":0.5235999822616577},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.46779999136924744},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4674000144004822},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4530999958515167},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.4300999939441681},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.40299999713897705},{"id":"https://openalex.org/C3017919176","wikidata":"https://www.wikidata.org/wiki/Q124292","display_name":"Biliary tract cancer","level":4,"score":0.3905999958515167},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3898000121116638},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.38929998874664307},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.3741999864578247},{"id":"https://openalex.org/C2775982439","wikidata":"https://www.wikidata.org/wiki/Q3562150","display_name":"Biliary tract","level":2,"score":0.3718000054359436},{"id":"https://openalex.org/C163763905","wikidata":"https://www.wikidata.org/wiki/Q17075943","display_name":"Precision medicine","level":2,"score":0.36169999837875366},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.31690001487731934},{"id":"https://openalex.org/C149172746","wikidata":"https://www.wikidata.org/wiki/Q2585693","display_name":"Efficacy","level":3,"score":0.3093000054359436},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.2996000051498413},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.29789999127388},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.2939000129699707},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.27810001373291016},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.2768000066280365},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.27239999175071716},{"id":"https://openalex.org/C2994119904","wikidata":"https://www.wikidata.org/wiki/Q1251001","display_name":"Drug response","level":3,"score":0.2669999897480011},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.25270000100135803},{"id":"https://openalex.org/C2780673598","wikidata":"https://www.wikidata.org/wiki/Q285223","display_name":"Genetic testing","level":2,"score":0.250900000333786}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2767-9764.c.8684414","doi":"https://doi.org/10.1158/2767-9764.c.8684414","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.c.8684414","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/2767-9764.c.8684414","doi":"https://doi.org/10.1158/2767-9764.c.8684414","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.c.8684414","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7202126691","https://openalex.org/W4406869970","https://openalex.org/W7204815506","https://openalex.org/W7204809751","https://openalex.org/W7204763602","https://openalex.org/W7204811812","https://openalex.org/W7204819033","https://openalex.org/W7204780376","https://openalex.org/W7204777687","https://openalex.org/W7214177811"],"abstract_inverted_index":{"Abstract":[0],"Biliary":[1],"tract":[2],"cancers":[3],"(BTC)":[4],"pose":[5],"clinical":[6],"challenges":[7],"due":[8],"to":[9,28,75,136,140,165,174,183],"poor":[10],"chemotherapy":[11],"response":[12],"and":[13,46,90,97,147,161,182],"aggressive":[14],"disease":[15],"course.":[16],"We":[17],"evaluated":[18],"patient-derived":[19],"tumor":[20,36],"organoid\u2013based":[21],"drug":[22,153],"sensitivity":[23,74],"testing":[24,117,154],"as":[25],"a":[26],"tool":[27],"guide":[29,184],"therapy.":[30],"In":[31,123],"this":[32],"multicenter":[33],"study,":[34],"26":[35],"organoids":[37,65,157],"were":[38,107],"successfully":[39],"derived":[40],"from":[41,67],"43":[42],"patients":[43,171],"with":[44,48,102,131,172],"BTC":[45],"tested":[47],"an":[49,132],"average":[50],"of":[51,85,155,179],"50":[52],"cancer-directed":[53],"therapies":[54],"using":[55],"the":[56,176],"Clinical":[57],"Laboratory":[58],"Improvement":[59],"Amendments\u2013certified":[60],"PARIS":[61],"assay.":[62],"Despite":[63],"most":[64],"being":[66],"late-stage":[68],"disease,":[69,146],"24/26":[70],"(92.3%)":[71],"exhibited":[72],"strong":[73],"one":[76,129],"or":[77],"more":[78],"targeted":[79],"agents.":[80],"Active":[81],"drugs":[82],"included":[83],"inhibitors":[84,138],"EGFR/HER2,":[86],"MEK,":[87],"ERK,":[88],"BCR-ABL":[89],"SRC":[91],"family,":[92],"mTOR,":[93],"PI3K,":[94],"MDM2,":[95],"BCL2,":[96],"BET.":[98],"Drug":[99],"sensitivities":[100],"aligned":[101],"known":[103],"genetic":[104],"biomarkers":[105],"but":[106],"also":[108],"observed":[109],"in":[110,186],"cultures":[111],"lacking":[112],"them,":[113],"indicating":[114],"ex":[115],"vivo":[116,152],"can":[118,162],"expand":[119],"actionability":[120],"beyond":[121],"genomics.":[122],"five":[124],"cases,":[125],"results":[126],"guided":[127],"therapy;":[128],"patient":[130],"FGFR-BICC1":[133],"fusion":[134],"refractory":[135],"FGFR":[137],"responded":[139],"dasatinib,":[141],"achieving":[142],"symptomatic":[143],"improvement,":[144],"stable":[145],">8-month":[148],"survival.":[149],"Significance:":[150],"Ex":[151],"tumor-derived":[156],"is":[158],"clinically":[159],"feasible":[160],"be":[163],"used":[164],"identify":[166],"personalized":[167],"treatment":[168,185],"options":[169],"for":[170],"BTC,":[173],"evaluate":[175],"functional":[177],"relevance":[178],"genomic":[180],"biomarkers,":[181],"real":[187],"time.":[188]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-09-01T00:00:00"}